Characteristics of [14C]Guanidinium Accumulation in NG 108‐15 Cell Exposed to Serotonin 5‐HT3 Receptor Ligands and Substance P

Abstract: In the presence of substance P (SP; 10 μM), serotonin (5‐HT; 1 μM) triggered a cation permeability in cells of the hybridoma (mouse neuroblastoma X rat glioma) clone NG 108‐15 that could be assessed by measuring the cell capacity to accumulate [14C]guanidinium for 10‐15 min at 37°C. In addition to 5‐HT (EC50, 0.33 μM), the potent 5‐HT3 receptor agonists 2‐methyl‐serotonin, phenylbiguanide, and m‐chlorophenylbiguanide, and quipazine, markedly increased [14C]guanidinium uptake in NG 108‐15 cells exposed to 10 μM SP. In contrast, 5‐HT3 receptor antagonists prevented the effect of 5‐HT. The correlation (r= 0.97) between the potencies of 16 different ligands to mimic or prevent the effects of 5‐HT on [14C]guanidinium uptake, on the one hand, and to displace [3H]zacopride specifically bound to 5‐HT3 receptors on NG 108‐15 cells, on the other hand, clearly demonstrated that [14C]guanidinium uptake was directly controlled by 5‐HT3 receptors. Various compounds such as inorganic cations (La3+, Mn2+, Ba2+, Ni2+, and Zn2+), D‐tubocurarine, and memantine inhibited [14C]guanidinium uptake in NG 108‐15 cells exposed to 5‐HT and SP, as expected from their noncompetitive antagonistic properties at 5‐HT3 receptors. However, ethanol (100 mM), which has been reported to potentiate the electrophysiological response to 5‐HT3 receptor stimulation, prevented the effects of 5‐HT plus SP on [14C]guanidinium uptake. The cooperative effect of SP on this 5‐HT3‐evoked response resulted neither from an interaction of the peptide with the 5‐HT3 receptor binding site nor from a possible direct activation of G proteins in NG 108‐15 cells. Among SP derivatives, [D‐Pro9]SP, a compound inactive at the various neurokinin receptor classes, was the most potent to mimic the stimulatory effect of SP on [14C]guanidinium uptake in NG 108‐15 cells exposed to 5‐HT. Although the cellular mechanisms involved deserve further investigations, the 5‐HT‐evoked [14C]guanidinium uptake appears to be a rapid and reliable response for assessing the functional state of 5‐HT3 receptors in NG 108‐15 cells.

[1]  R. North,et al.  5-HT3 receptors are membrane ion channels , 1989, Nature.

[2]  J. Garthwaite,et al.  NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway , 1991, Neuroscience Letters.

[3]  J. Plomp,et al.  Kinetics of the membrane current mediated by serotonin 5‐HT3 receptors in cultured mouse neuroblastoma cells. , 1989, The Journal of physiology.

[4]  D. Lovinger Ethanol potentiation of 5-HT3 receptor-mediated ion current in NCB-20 neuroblastoma cells , 1991, Neuroscience Letters.

[5]  H. Higashi,et al.  5‐Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia , 1982, The Journal of physiology.

[6]  D. Lodge,et al.  Noncompetitive excitatory amino acid receptor antagonists. , 1990, Trends in pharmacological sciences.

[7]  J. A. Peters,et al.  Physiological and pharmacological properties of 5-HT3 receptors — A patch clamp-study , 1991, Neuropeptides.

[8]  M. Reith,et al.  [14C]guanidinium ion influx into Na+ channel preparations from mouse cerebral cortex. , 1990, European journal of pharmacology.

[9]  T. Dwyer,et al.  The permeability of the endplate channel to organic cations in frog muscle , 1980, The Journal of general physiology.

[10]  M. Jackson,et al.  The selectivity of the channel coupled to the 5-HT3 receptor , 1990, Brain Research.

[11]  J. A. Peters,et al.  The properties of 5‐HT3 receptors in clonal cell lines studied by patch‐clamp techniques , 1989, British journal of pharmacology.

[12]  M. Jackson,et al.  Differentiation of NG108-15 cells alters channel conductance and desensitization kinetics of the 5-HT3 receptor. , 1991, Journal of neurophysiology.

[13]  B. Hamprecht Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture. , 1977, International review of cytology.

[14]  B. Costall,et al.  [3H]Zacopride: Ligand for the Identification of 5‐HT3 Recognition Sites , 1988, The Journal of pharmacy and pharmacology.

[15]  T. Narahashi,et al.  Cation selectivity of acetylcholine-activated ionic channel of frog endplate , 1979, The Journal of general physiology.

[16]  I. Martin,et al.  Molecular biology of 5-HT receptors , 1994, Neuropharmacology.

[17]  G. Reiser,et al.  Characterization of a substance P receptor activating a cation permeability in neuronal cell lines. , 1988, European journal of pharmacology.

[18]  G. Reiser,et al.  Serotonin raises the cyclic GMP level in a neuronal cell line via 5-HT3 receptors. , 1989, European journal of pharmacology.

[19]  J. Yang,et al.  Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells , 1990, The Journal of general physiology.

[20]  S. Zukin,et al.  Kinetic mechanisms of glycine requirement for N-methyl-d-aspartate channel activation , 1991, Brain Research.

[21]  B. Costall,et al.  Agonist interactions with 5‐HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands , 1992, British journal of pharmacology.

[22]  J. Bockaert,et al.  Direct activation of GTP‐binding regulatory proteins (G‐proteins) by substance P and compound 48/80 , 1990, FEBS letters.

[23]  J. Bockaert,et al.  Interaction of substance P, compound 4880 and mastoparan with the α-subunit C-terminus of G protein , 1990 .

[24]  P. Hartig Molecular biology of 5-HT receptors. , 1989, Trends in pharmacological sciences.

[25]  R. Myers,et al.  Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.

[26]  J. Bockaert,et al.  Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. , 1990, Immunology letters.

[27]  J. Lowe,et al.  A potent nonpeptide antagonist of the substance P (NK1) receptor. , 1991, Science.

[28]  A. Round,et al.  Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists , 1987, Neuropharmacology.

[29]  B. Richardson,et al.  The pharmacology and function of 5-HT3receptors , 1986, Trends in Neurosciences.

[30]  S. Watson,et al.  Tachykinin receptor types: Classification and membrane signalling mechanisms , 1991, Neurochemistry International.

[31]  G. Reiser,et al.  Substance P and serotonin act synergistically to activate a cation permeability in a neuronal cell line , 1989, Brain Research.

[32]  R. North,et al.  The action of 5-hydroxytryptamine on single neurones of the rabbit superior cervical ganglion , 1978, Neuropharmacology.

[33]  E. Ross,et al.  Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). , 1988, The Journal of biological chemistry.

[34]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[35]  M. B. Tyers,et al.  Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerve , 1987, British journal of pharmacology.

[36]  A. Yang,et al.  Influence of the freezing process upon fluoride binding to hemeproteins. , 1991, Biophysical journal.

[37]  A. Surprenant,et al.  Electrophysiological characterization of functionally distinct 5-hydroxytryptamine receptors on guinea-pig submucous plexus , 1988, Neuroscience.

[38]  G. Reiser,et al.  Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell line. , 1989, European journal of pharmacology.

[39]  M. Jackson,et al.  5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line , 1988, Neuron.

[40]  K. Watling Radioligand binding studies identify 5-HT3 recognition sites in neuroblastoma cell lines and mammalian CNS. , 1988, Trends in pharmacological sciences.

[41]  M. Hamon,et al.  Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells. , 1990, Biochemical pharmacology.

[42]  M. Hamon,et al.  Physicochemical Properties of Serotonin 5‐HT3 Binding Sites Solubilized from Membranes of NG 108‐15 Neuroblastoma‐Glioma Cells , 1990, Journal of neurochemistry.

[43]  Gavin Kilpatrick,et al.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding , 1987, Nature.

[44]  P. Krogsgaard‐Larsen GABA and glutamate receptors as therapeutic targets in neurodegenerative disorders. , 1992, Pharmacology & toxicology.

[45]  G. Reiser,et al.  Serotonin regulates cytosolic Ca2+ activity and membrane potential in a neuronal and in a glial cell line via 5-HT3 and 5-HT2 receptors by different mechanisms. , 1989, Journal of cell science.

[46]  C. Bronner,et al.  G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. , 1990, Trends in pharmacological sciences.